A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
Clinical trial NCT05662332 · COMPLETED
Trial details
- NCT number
- NCT05662332
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-14
- Primary completion
- 2024-07-19
- Enrollment
- 795
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.